Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Routine clinical use is accelerating, driven by advanced image quality, expanding clinical utility, and increasingly diverse use cases across hospital and office settings.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the achievement of scan volume milestones in key hospitals and neurology clinics, demonstrating accelerating clinical utilization and adoption of the Swoop® system throughout the United States.
The increasing clinical use of the Swoop® system is driven by several factors: enhanced clinical utility from improved image quality, growing evidence of its economic value, and expanding adoption across new care settings, including neurology clinics and the emergency department (ED). The most successful Swoop® system programs are driven by visionary healthcare leaders who are passionate about addressing the challenges of MRI availability and recognize the clinical and economic value of portable MRI in expanding patient access to imaging.
